Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status
Authors:
- 27 October 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (12) , 1320-1332
Abstract
Background Several gene therapy strategies have been designed for cancer treatment. Intra‐tumoral injection of adenoviruses expressing pro‐drug‐converting enzymes is one such strategy. Although the efficacy of these therapies was tested in animal models, little work has been devoted to the determination of critical variables for success. In this work, we aimed at better understanding variables that affect the cytosine deaminase::uracil phosphoribosyl transferase (CD::UPRT)‐based strategy in two human glioblastomas. Methods We have constructed two adenoviruses expressing either CD or the fusion protein CD::UPRT. We have tested their anti‐tumor activity in combination with 5‐fluorocytosine (5‐FC) in the glioblastoma cell lines U87 and U251, which are p53‐wt and p53‐deficient, respectively. Anti‐tumor activity has also been investigated in spheroid structures. Results The superiority of CD::UPRT over CD was confirmed in both glioblastoma cells. We found that the pro‐drug concentration required for anti‐tumor activity was 9‐fold higher in U251 than in U87, while multiplicity of infection (MOI) as low as 6 was sufficient to achieve 50% killing. Bystander activity was observed with as few as 2 and 6% transduced cells for U87 and U251, respectively. Differences in sensitivity between U87 and U251 were not due to differences in transduction, transgene expression, or intercellular transport, but were related to 5‐FU sensitivity and p53 status. Also, it is noteworthy that, in contrast to U87, U251 spheroids barely responded to the treatment, whereas their monolayer counterparts were very sensitive. Conclusions Our study has shown that p53 status is important for CD::UPRT/5‐FC treatment. Moreover, this study demonstrated that the three‐dimensional spheroid model is a more stringent in vitro model for suicide gene therapy evaluation than are monolayer cultures. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancerCancer Gene Therapy, 2003
- Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectivesJournal of Cellular Physiology, 2001
- Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracilEuropean Journal of Cancer, 2000
- Adenoviral-Mediated p53 Gene Transfer to Non-small Cell Lung Cancer Through Endobronchial InjectionChest, 2000
- A Phase I/II Study of Hepatic Artery Infusion with wtp53-CMV-Ad in Metastatic Malignant Liver TumoursHuman Gene Therapy, 1999
- Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.Brain Pathology, 1999
- Resistance to 5-FluorouracilGeneral Pharmacology: The Vascular System, 1998
- Primary central nervous system tumors: advances in knowledge and treatmentCA: A Cancer Journal for Clinicians, 1998
- Central nervous system tumors: what have we learned and where are we heading?CA: A Cancer Journal for Clinicians, 1998
- Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status.Journal of Neuropathology & Experimental Neurology, 1997